These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35190974)

  • 21. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
    Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z
    Front Immunol; 2020; 11():1936. PubMed ID: 32849650
    [No Abstract]   [Full Text] [Related]  

  • 22. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months.
    Zheng Y; Zhang Q; Ali A; Li K; Shao N; Zhou X; Ye Z; Chen X; Cao S; Cui J; Zhou J; Wang D; Hou B; Li M; Cui M; Deng L; Sun X; Zhang Q; Yang Q; Li Y; Wang H; Lei Y; Yu B; Cheng Y; Tong X; Men D; Zhang XE
    Virol Sin; 2021 Oct; 36(5):869-878. PubMed ID: 33661489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [SARS-CoV-2 antibodies kinetics in hospitalized patients].
    Zuanich C; Garcia Rosolen N; Olmos Vargas P; Arévalo D; Donati P; Balbaryski J
    Medicina (B Aires); 2022; 82(1):3-12. PubMed ID: 35037855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection.
    Lijia S; Lihong S; Huabin W; Xiaoping X; Xiaodong L; Yixuan Z; Pin H; Yina X; Xiaoyun S; Junqi W
    J Clin Lab Anal; 2020 Oct; 34(10):e23466. PubMed ID: 32671890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
    Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P
    Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
    Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A
    New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
    Chen J; Niu Z; Li H; Tang D; Zhang P
    Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal anti-SARS-CoV-2 antibody immune response in acute and convalescent patients.
    Pérez-Juárez H; Serrano-Vázquez A; Godínez-Alvarez H; González E; Rojas-Velázquez L; Moran P; Portillo-Bobadilla T; Ramiro M; Hernández E; Lau C; Martínez M; Padilla MLÁ; Zaragoza ME; Taboada B; Palomares LA; López S; Alagón A; Arias CF; Ximénez C
    Front Cell Infect Microbiol; 2023; 13():1239700. PubMed ID: 37743860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS).
    Mitani A; Hamada K; Yoshikawa N; Morita Y; Horie T; Inoue Y; Saito M; Ishii T; Sunohara M; Takahashi R; Emoto N; Nishimoto N; Murano Y; Okazaki S; Tateishi S; Yao A; Shimura T; Kurano M; Yatomi Y; Yanagimoto S
    J Infect Chemother; 2021 Sep; 27(9):1342-1349. PubMed ID: 34158239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.
    Jiang HW; Li Y; Zhang HN; Wang W; Yang X; Qi H; Li H; Men D; Zhou J; Tao SC
    Nat Commun; 2020 Jul; 11(1):3581. PubMed ID: 32665645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases.
    Ou J; Tan M; He H; Tan H; Mai J; Long Y; Jiang X; He Q; Huang Y; Li Y; Chen R; Li L; Shi Y; Li F
    J Appl Lab Med; 2021 Sep; 6(5):1133-1142. PubMed ID: 34329427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between IgG and IgM levels and severity of symptoms in COVID-19 patients confirmed by rapid antigen test.
    Al-Ibraheemi JSS; Al-Saeedi AS
    J Med Life; 2021; 14(6):790-796. PubMed ID: 35126749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.
    Zhang LX; Miao SY; Qin ZH; Wu JP; Chen HY; Sun HB; Xie Y; Du YQ; Shen J
    Mol Diagn Ther; 2020 Oct; 24(5):601-609. PubMed ID: 32710269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown.
    Tang Y; Sun J; Yuan Y; Yao F; Zheng B; Yang G; Xie W; Ye G; Li Z; Jiao X; Li Y
    BMC Infect Dis; 2022 Jan; 22(1):10. PubMed ID: 34983429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of Detection of Anti-SARS-CoV-2 IgG/IgM and SARS-CoV-2 RNA in Respiratory Tract Specimens in 48 COVID-19 Patients.
    Wu E; Zhang X; Zheng Y; Luo Z; Zhai W; Yin Z; Chen D; Wang Z; Zhai J; Han Y; Liu H; Li R; Wang Y; Feng Y; Shi G; Ma Y
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value and Validity of Coronavirus Antibody Testing.
    Mahajan A; Manchikanti L
    Pain Physician; 2020 Aug; 23(4S):S381-S390. PubMed ID: 32942795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.